EUCTR2006-004968-32-IT进行中（未招募）1 期
Protocol for therapeutic use of Posaconazolo out of clinical trials in patients with invasive resistant micosis and/or in tolerant patients. - ND
OSPEDALE S. RAFFAELE0 个研究点目标入组 100 人开始时间: 2007年1月10日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-aspergillosis-fusariosis-cromoblastomicosis-coccidiomicosis
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-pregnancy and breastfeeding;-hypersensibility to azolic anti micotics; -subjects in treatment with vinca or antracicline 24 hours before posaconazolo treatment or subject requiring vinca or antracicline therapy for 30 days or more
研究者
相似试验
进行中（未招募）
1 期
Open-Label, limited access protocol of Posaconazole in invasive fungal infections.EUCTR2005-003717-33-ITSCHERING-PLOUGH
已完成
3 期
Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095)MycosesNCT00034632Merck Sharp & Dohme LLC
已完成
3 期
Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041)MycosesNCT00034658Merck Sharp & Dohme LLC336
进行中（未招募）
1 期
Study of posaconazole prophylaxis in patients receiving hematopoietic stem cell allograft (allo-HSC) at high risk of invasive fungal infection (IFI): POSALLO study30 adult patients due to receive an allograft for a myeloid or lymphoid hematological malignancy with an HLA-matched donor from the family or from the international donor file will be included in the hematology departments of the Nantes University Hospital.CTIS2024-511507-42-00Centre Hospitalier Universitaire De Nantes30
进行中（未招募）
不适用
A Study to Look at the Way the Body Absorbs and Distributes Posaconazole in the Blood and Lungs of Lung Transplant Recipients (PAPAL Study)Invasive fungal infection (IFI) in lung transplant patients with and without cystic fibrosis.MedDRA version: 15.0Level: PTClassification code 10049085Term: Antifungal prophylaxisSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2012-003140-68-GBMSD40